Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups. - Gisslinger H; Klade C; Georgiev P; Krochmalczyk D; Gercheva-Kyuchukova L; Egyed M; Rossiev V; Dulicek P; Illes A; Pylypenko H; Sivcheva L; Mayer J; et al. (HemaSphere, 2020)